Surgical safety of immediate versus deferred cytoreductive nephrectomy (CN) in patients with synchronous metastatic renal cell carcinoma (mRCC) receiving sunitinib. Data from the EORTC randomized trial 30073 SURTIMEAxel Bex, John Haanen, Michael Jewett et al.|European Urology Supplements|2018Cited by 7